Navigation Links
GW professor to examine infections in HIV patients with federal grant
Date:11/26/2012

WASHINGTON (Nov. 26, 2012) Imtiaz A. Khan, M.D., professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, received a $1.6 million federal grant from the National Institute of Allergy and Infectious Diseases to study the effects of microsporidiaopportunistic inter-cellular pathogensthat cause morbidity and mortality in HIV patients.

Fifteen years ago, Khan saw that this type of infection was becoming a major problem in HIV populations. He realized little had been researched about immune response to these pathogens. After looking into the matter further, he saw that CD8+ T cells played a critical role in protecting against these pathogens.

His project, titled "CD8+ T cell effectors against microsporidia," will study how to prevent microsporidia from causing complications in immunocompromised subjects by regulating CD8+ T cells. These highly understudied cells are tolerated and controlled in healthy, immunocompetent individuals. For the elderly or individuals with HIV, these cells can cause problems. In order to stave off infection for the immunocompromised, the cells need to be maintained and regenerated.

"The question is, how can you generate CD8 effectively, so this infection does not harm them?" said Khan. "Because CD8+ T cells are critical, how can you maintain a good CD8 cell population, so this group of pathogens doesn't reemerge?"

Khan and his research team will be using cytokines and other therapeutic methods to generate highly functional CD8+ T cells to create and maintain robust immunity against these pathogens, improving the mortality and quality of life of many HIV patients.

This research may not only benefit those suffering from microspordia, but can be extended to other infections effecting HIV populations, as well.


'/>"/>

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University
Source:Eurekalert

Page: 1

Related biology news :

1. Michael Barnett of Boston College named Professor of the Year for Massachusetts
2. NJIT professor promotes building material of millennium: Autoclave aerated concrete
3. The IPCC Report on Climate Change - Swedish professor Thomas Sterner selected as 1 of the experts
4. Louisiana Tech University professor earns national honor from Society of American Foresters
5. New book on physics principles by Wayne State professor explains life as we know it
6. SMU professor Louis Jacobs honored with prestigious award from Texas science teachers
7. Professor publishes on first-ever imaging of cells growing on spherical surfaces
8. UA engineering professor Shane Snyder to speak in Korea on international water quality
9. National herpetology society honors UT Arlington professor for discoveries
10. GW professor receives grant to study the role of genes in drug addiction
11. Professors Antarctica research shows potential king crab invasion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... -- Trovagene, Inc. (NASDAQ: TROV ), a developer ... it has signed agreements with seven strategic partners across ... Middle East for commercialization of the Trovera™ ... of international distribution agreements for Trovagene,s CLIA based liquid ... The initial partners will introduce Trovagene,s liquid biopsy tests ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
(Date:1/3/2017)... Onitor, provider of digital health technology for ... innovative biometric data-driven program designed to aid weight loss ... 2017 Consumer Electronics Show (CES) in Las ... the World Health Organization (WHO), have identified lifestyle risks ... are overweight or obese. WHO also states that more ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... ... January 17, 2017 , ... One Million Solutions ... (SafeTEC™), $3 million in investment towards 15+ TEC Validation Projects™. As a pre-competitive ... their applicability in drug safety assessment, for the industry as a whole. , ...
(Date:1/17/2017)... -- On January 10 at the Medtech Showcase held in ... in San Francisco , ProclaRx CEO, ... pharmaceutical leaders and public and private investors about the ... destroy biofilms.  Biofilms are a physical ... body,s immune system from eradicating chronic infections. Infections with biofilms ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today ... will allow more customers to receive their primers in ... or compromise in quality found with other providers. Express ... United States at no additional fee. ... routine genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, ...
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global ... ... CAGR of 16.83% during the period 2017-2021. The report ... market for 2017-2021. To calculate the market size, the report considers the ... also includes a a discussion of the key vendors operating in this ...
Breaking Biology Technology: